Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Figure out How to Ascertain the Restitution Time frame for Your Sunlight based chargers - 2This Is Canada's Only Province Without Any Bears
- 3Accor signs agreement to transform El Gouna resort as Sofitel
- 4Genome study reveals milestone in history of cat domestication
- 56 Famous Urban communities for Shopping on the planet
- Involved Vehicles for Seniors: Track down the Best Picks for Solace and Dependability
- Tuesday, April 7. Russia’s War On Ukraine: News And Information From Ukraine
- Countdown begins for long-awaited Artemis II moon mission
- What do scientists hope to learn from NASA's historic Artemis 2 moon flyby?
- ‘This year nearly broke me as a scientist’ – US researchers reflect on how 2025’s science cuts have changed their lives
- 2 ways you can conserve the water used to make your food
- Must-See Attractions in France
- A Time of Careful Eating: Individual Tests in Nourishment
- Oldest sequenced RNA reveals details about a mammoth’s final moments 40,000 years
